Pliant Therapeutics Stock Price History
| PLRX Stock | USD 1.55 0.03 1.90% |
Below is the normalized historical share price chart for Pliant Therapeutics extending back to June 03, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Pliant Therapeutics stands at 1.55, as last reported on the 22nd of March, with the highest price reaching 1.66 and the lowest price hitting 1.52 during the day.
If you're considering investing in Pliant Stock, it is important to understand the factors that can impact its price. Pliant Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.17, which implies the firm had a -0.17 % return per unit of risk over the last 3 months. Pliant Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pliant Therapeutics' Variance of 157.16, coefficient of variation of (611.71), and Risk Adjusted Performance of (0.14) to confirm the risk estimate we provide.
At this time, Pliant Therapeutics' Common Stock Total Equity is fairly stable compared to the past year. Sale Purchase Of Stock is likely to rise to about 260.4 M in 2025, whereas Total Stockholder Equity is likely to drop slightly above 216.6 M in 2025. . At this time, Pliant Therapeutics' Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 2.75 in 2025, despite the fact that Price Earnings Ratio is likely to grow to (3.60). Pliant Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of June 2020 | 200 Day MA 11.2177 | 50 Day MA 6.2756 | Beta 1.186 |
Pliant |
Sharpe Ratio = -0.1703
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PLRX |
Estimated Market Risk
| 13.09 actual daily | 96 96% of assets are less volatile |
Expected Return
| -2.23 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.17 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pliant Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pliant Therapeutics by adding Pliant Therapeutics to a well-diversified portfolio.
Price Book 0.3262 | Enterprise Value Ebitda (2.54) | Price Sales 3.1 K | Shares Float 50.2 M | Wall Street Target Price 10.0625 |
Pliant Therapeutics Stock Price History Chart
There are several ways to analyze Pliant Stock price data. The simplest method is using a basic Pliant candlestick price chart, which shows Pliant Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 26, 2024 | 14.03 |
| Lowest Price | March 4, 2025 | 1.35 |
Pliant Therapeutics March 22, 2025 Stock Price Synopsis
Various analyses of Pliant Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Pliant Stock. It can be used to describe the percentage change in the price of Pliant Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Pliant Stock.| Pliant Therapeutics Accumulation Distribution | 329,606 | |
| Pliant Therapeutics Price Daily Balance Of Power | (0.21) | |
| Pliant Therapeutics Price Rate Of Daily Change | 0.98 | |
| Pliant Therapeutics Price Action Indicator | (0.05) |
Pliant Therapeutics March 22, 2025 Stock Price Analysis
Pliant Stock Price History Data
The price series of Pliant Therapeutics for the period between Sun, Dec 22, 2024 and Sat, Mar 22, 2025 has a statistical range of 13.02 with a coefficient of variation of 61.76. The price distribution for the period has arithmetic mean of 8.22. The median price for the last 90 days is 10.92.| Open | High | Low | Close | Volume | ||
| 03/21/2025 | 1.56 | 1.66 | 1.52 | 1.55 | 3,908,186 | |
| 03/20/2025 | 1.59 | 1.62 | 1.53 | 1.58 | 771,389 | |
| 03/19/2025 | 1.66 | 1.70 | 1.60 | 1.62 | 2,828,828 | |
| 03/18/2025 | 1.65 | 1.72 | 1.59 | 1.69 | 3,003,421 | |
| 03/17/2025 | 1.55 | 1.78 | 1.54 | 1.70 | 3,204,834 | |
| 03/14/2025 | 1.54 | 1.60 | 1.52 | 1.54 | 1,321,554 | |
| 03/13/2025 | 1.59 | 1.61 | 1.50 | 1.52 | 1,111,512 | |
| 03/12/2025 | 1.59 | 1.62 | 1.51 | 1.58 | 1,275,600 | |
| 03/11/2025 | 1.63 | 1.68 | 1.46 | 1.57 | 2,249,070 | |
| 03/10/2025 | 1.59 | 1.67 | 1.38 | 1.43 | 2,112,470 | |
| 03/07/2025 | 1.58 | 1.66 | 1.55 | 1.62 | 1,636,207 | |
| 03/06/2025 | 1.50 | 1.64 | 1.50 | 1.58 | 1,893,312 | |
| 03/05/2025 | 1.33 | 1.61 | 1.26 | 1.52 | 8,309,742 | |
| 03/04/2025 | 1.44 | 1.52 | 1.27 | 1.35 | 7,489,147 | |
| 03/03/2025 | 3.10 | 3.25 | 1.37 | 1.38 | 19,449,486 | |
| 02/28/2025 | 3.18 | 3.46 | 3.13 | 3.44 | 3,924,106 | |
| 02/27/2025 | 3.07 | 3.36 | 3.07 | 3.26 | 2,855,185 | |
| 02/26/2025 | 3.18 | 3.32 | 3.07 | 3.12 | 2,173,238 | |
| 02/25/2025 | 3.06 | 3.20 | 2.99 | 3.17 | 3,138,497 | |
| 02/24/2025 | 3.10 | 3.14 | 3.01 | 3.03 | 1,581,921 | |
| 02/21/2025 | 3.05 | 3.13 | 3.00 | 3.08 | 2,090,227 | |
| 02/20/2025 | 2.97 | 3.16 | 2.92 | 3.01 | 3,631,909 | |
| 02/19/2025 | 3.00 | 3.11 | 2.94 | 3.00 | 2,557,860 | |
| 02/18/2025 | 3.06 | 3.22 | 2.93 | 2.98 | 1,714,484 | |
| 02/14/2025 | 3.15 | 3.49 | 2.99 | 3.04 | 3,588,086 | |
| 02/13/2025 | 3.08 | 3.78 | 3.05 | 3.29 | 15,004,401 | |
| 02/12/2025 | 2.57 | 2.74 | 2.43 | 2.72 | 3,502,985 | |
| 02/11/2025 | 3.03 | 3.07 | 2.60 | 2.61 | 5,299,328 | |
| 02/10/2025 | 3.02 | 3.43 | 2.82 | 3.07 | 20,039,350 | |
| 02/07/2025 | 11.82 | 11.96 | 7.18 | 7.79 | 5,761,664 | |
| 02/06/2025 | 12.56 | 12.77 | 11.93 | 11.95 | 356,756 | |
| 02/05/2025 | 11.47 | 12.88 | 11.37 | 12.55 | 565,077 | |
| 02/04/2025 | 11.20 | 11.46 | 10.96 | 11.37 | 319,214 | |
| 02/03/2025 | 10.50 | 11.22 | 10.35 | 11.18 | 641,204 | |
| 01/31/2025 | 10.68 | 11.06 | 10.54 | 10.75 | 531,019 | |
| 01/30/2025 | 10.86 | 11.07 | 10.58 | 10.66 | 488,002 | |
| 01/29/2025 | 10.82 | 11.03 | 10.70 | 10.74 | 410,036 | |
| 01/28/2025 | 11.02 | 11.08 | 10.78 | 10.91 | 545,007 | |
| 01/27/2025 | 11.03 | 11.40 | 10.85 | 11.00 | 677,797 | |
| 01/24/2025 | 11.15 | 11.29 | 10.81 | 10.92 | 434,462 | |
| 01/23/2025 | 10.74 | 11.40 | 10.68 | 11.14 | 818,489 | |
| 01/22/2025 | 10.98 | 11.25 | 10.78 | 10.92 | 700,768 | |
| 01/21/2025 | 11.07 | 11.40 | 11.04 | 11.07 | 681,649 | |
| 01/17/2025 | 11.65 | 11.73 | 10.94 | 11.21 | 672,617 | |
| 01/16/2025 | 12.61 | 12.61 | 11.60 | 11.60 | 415,729 | |
| 01/15/2025 | 11.78 | 12.70 | 11.50 | 12.63 | 533,913 | |
| 01/14/2025 | 11.86 | 11.94 | 11.02 | 11.24 | 380,044 | |
| 01/13/2025 | 11.74 | 12.12 | 11.20 | 11.77 | 405,747 | |
| 01/10/2025 | 12.26 | 12.39 | 11.82 | 12.01 | 350,429 | |
| 01/08/2025 | 13.27 | 13.27 | 12.60 | 12.61 | 213,882 | |
| 01/07/2025 | 13.18 | 13.46 | 12.73 | 13.27 | 371,732 | |
| 01/06/2025 | 13.55 | 13.68 | 13.02 | 13.18 | 351,223 | |
| 01/03/2025 | 13.42 | 13.71 | 13.23 | 13.53 | 459,945 | |
| 01/02/2025 | 13.29 | 13.40 | 12.80 | 13.28 | 376,965 | |
| 12/31/2024 | 12.87 | 13.20 | 12.40 | 13.17 | 430,041 | |
| 12/30/2024 | 13.36 | 13.70 | 12.59 | 12.79 | 337,440 | |
| 12/27/2024 | 13.98 | 14.23 | 13.48 | 13.56 | 364,368 | |
| 12/26/2024 | 13.34 | 14.26 | 13.02 | 14.03 | 446,981 | |
| 12/24/2024 | 13.34 | 13.55 | 13.18 | 13.49 | 345,814 | |
| 12/23/2024 | 13.18 | 13.44 | 12.53 | 13.34 | 819,922 | |
| 12/20/2024 | 13.11 | 13.85 | 13.07 | 13.21 | 1,882,894 |
About Pliant Therapeutics Stock history
Pliant Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pliant is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pliant Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pliant Therapeutics stock prices may prove useful in developing a viable investing in Pliant Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 60.5 M | 44.7 M | |
| Net Loss | -111 M | -105.4 M |
Pliant Therapeutics Quarterly Net Working Capital |
|
Pliant Therapeutics Stock Technical Analysis
Pliant Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
Pliant Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pliant Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Pliant Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pliant to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (2.05) | |||
| Total Risk Alpha | (1.04) | |||
| Treynor Ratio | (12.09) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Pliant Stock Analysis
When running Pliant Therapeutics' price analysis, check to measure Pliant Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant Therapeutics is operating at the current time. Most of Pliant Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pliant Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant Therapeutics' price. Additionally, you may evaluate how the addition of Pliant Therapeutics to your portfolios can decrease your overall portfolio volatility.